Miolisodal
Brand names,
Miolisodal
Analogs
Miolisodal
Brand Names Mixture
Miolisodal
Chemical_Formula
C12H24N2O4
Miolisodal
RX_link
http://www.rxlist.com/cgi/generic/carisop.htm
Miolisodal
fda sheet
Miolisodal
msds (material safety sheet)
Miolisodal
Synthesis Reference
Berger, Ludwig, U.S. Pat. 2,937,119 (1960)
Miolisodal
Molecular Weight
260.33 g/mol
Miolisodal
Melting Point
92-93 oC
Miolisodal
H2O Solubility
0.3 mg/ml
Miolisodal
State
Solid
Miolisodal
LogP
1.498
Miolisodal
Dosage Forms
Talets
Miolisodal
Indication
For the relief of discomfort associated with acute, painful, musculoskeletal conditions.
Miolisodal
Pharmacology
Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an anxiolytic agent.
Miolisodal
Absorption
No information avaliable
Miolisodal
side effects and Toxicity
Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension. Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such additives
Miolisodal
Patient Information
Carisoprodol is a muscle relaxant used to relieve the pain and stiffness of muscle spasms and discomfort due to
strain and sprain. Inform your physician if you are pregnant or nursing. Do not take this medication with a monoamine
oxidase inhibitor. This medication may cause dizziness, drowsiness, or blurred vision; use caution while driving or
operating hazardous machinery. Do not take any other sedating drugs or drink alcohol while taking carisoprodol. If
dizziness occurs, avoid sudden changes in posture. Take this medication with food to avoid stomach upset. Notify your
physician if you develop trouble breathing, unexplained fever, severe weakness, vision changes, swelling, or skin
rash. Withdrawal symptoms may occur if therapy is suddenly stopped in a patient on long-term or high-dose
therapy.
Miolisodal
Organisms Affected
Humans and other mammals